NCT03643783View on ClinicalTrials.gov

Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
ObesityType2 DiabetesBariatric Surgery Candidate
Trial Locations (1)

70112

Tulane Medical Center, New Orleans

All Listed Sponsors
collaborator

Tulane University Health Sciences Center

OTHER

collaborator

UAB-CCTS Network Mulitdisciplinary Pilot Program

UNKNOWN

lead

Tulane University

OTHER

NCT03643783 - Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter